학술논문
Iruplinalkib (WX-0593) Versus Crizotinib in ALK TKI-Naive Locally Advanced or Metastatic ALK-Positive NSCLC: Interim Analysis of a Randomized, Open-Label, Phase 3 Study (INSPIRE)
Document Type
Article
Author
Shi, Yuankai; Chen, Jianhua; Yang, Runxiang; Wu, Hongbo; Wang, Zhehai; Yang, Weihua; Cui, Jiuwei; Zhang, Yiping; Liu, Chunling; Cheng, Ying; Liu, Yunpeng; Shan, Jinlu; Wang, Donglin; Yang, Lei; Hu, Changlu; Zhao, Jian; Cao, Ranhua; Tan, Bangxian; Xu, Ke; Si, Meimei; Li, Hui; Mao, Ruifeng; Li, Lingyan; Kang, Xiaoyan; Wang, Lin
Source
In Journal of Thoracic Oncology January 2024
Subject
Language
ISSN
1556-0864